A screen shows Russian President Vladimir Putin during the 15th annual year-end press conference at the World Trade Center in Moscow.
President Vladimir Putin said Tuesday that Russia was about to register its third vaccine against the coronavirus, according to Russian news agencies.
Putin also said that “all” Russian coronavirus vaccines were effective, The RIA news agency reported. He didn’t seem to give any further details about the vaccine or its registration.
He said Moscow is ready to work with all other countries on vaccines but warned against the “politicization” of the process.
“I agree that such a vaccine should belong to all of humanity,” Putin said at the Shanghai Cooperation Organization summit Tass news agency. “We are ready to work with all countries, including our SCO partners.”
The comments came a day after US drug company Pfizer and German biotechnology company BioNTech announced preliminary results from late-stage clinical trials showed it The coronavirus vaccine was 90% effective in preventing Covid-19 in patients with no evidence of previous infection.
The news shot up global equity markets and cautious optimism among Western governments.
Pharmaceutical companies, health officials, and vaccine researchers at academic institutions have been trying at breakneck speed to find a coronavirus vaccine.
Pfizer’s news seems to mark a breakthrough, but the vaccine isn’t the only one in development.
According to the Johns Hopkins University, the country has the fifth highest number of coronavirus infections in the world. To date, nearly 1.8 million cases have been confirmed.
The announcement of the Russian vaccine Covid-19 in August raised concerns among some members of the international scientific community about the speed of approval – the vaccine had not yet begun Phase 3 trials – and the lack of available data to support the Russian claims The effectiveness and effectiveness of the vaccine support Safety – No results from previous studies have been published.
In September, the Gamaleya Epidemiology and Microbiology Research Institute of Russia, which was developing the vaccine, published early-stage study results in the medical journal The Lancet The reliability of the data has been questioned by a group of scientists.
Russia’s vaccine developers now say that clinical trials of the third stage of the vaccine with 40,000 volunteers are underway in Russia. Studies have been announced in the United Arab Emirates, India, Venezuela and Belarus.
Mid October Russia announced that it has approved a second coronavirus vaccineIn this case, too, approval was granted before material results were published and a large-scale phase 3 trial commenced, Reuters reported.
On Monday, Kirill Dmitriev, the head of the Russian state fund that supports the development of the Sputnik V vaccine, said Russia would publish clinical trials with preliminary efficacy data in November. Sputnik News reported.
On Monday, following Pfizer’s announcement, a representative from the Russian Ministry of Health said the Sputnik V vaccine was also more than 90% effective. Reuters reported.